Overview: An Oklahoma woman is suing Bayer after suffering from a severe case of deep vein thrombosis that resulted in the amputation of her left arm. Her lawsuit alleges that the popular birth control pill Yaz caused the catastrophic blood clot, which has devastated her entire family. Yaz and Yasmin are two similar types of birth control pills that were advertised by the company as being a superior type of oral contraceptive, but lawsuits against the company have alleged that they caused serious and sometimes fatal blood clots.
- An Oklahoma woman has filed a lawsuit alleging that Bayer’s Yaz caused deep vein thrombosis in her left arm leading to an amputation
- There are over 12,000 lawsuits alleging Yaz, Yasmin or Ocella caused injuries
- Yaz and Yasmin are allegedly dangerous because they contain drospirenone, a synthetic hormone; research has shown that these types of birth control pills are associated with a higher risk of blood clots
Product: Yaz®, Yasmin® (Drospirenone and Ethinyl Estradiol)
Manufacturer: Bayer AG
Side Effects & Complications
- Blood Clots
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Gallbladder Damage
- Heart Attacks
Yaz Injuries and Litigation
Brandy Armantrout, a 32-year old Oklahoma woman who started taking Bayer’s Yaz birth control pill in 2007, has filed a lawsuit alleging that the contraceptive has caused devastating injuries. She alleges in her lawsuit that in December 2012, she began to feel a tingling sensation in her left arm. Mrs. Armantrout went to a local hospital to seek emergency treatment; there, doctors found that she had a severe case of deep vein thrombosis, where a blood clot forms in one of the deep veins of the body. Sadly, her injuries were too severe and doctors had to amputate her left arm above the elbow. The amputation has greatly affected Brandy and her family. To make matters worse, her medical insurance company told her that she was not covered for prosthetics.
Brandy’s lawsuit is one of 12,000 alleging injuries from Yaz or its sister pills Yasmin and Ocella. A significant portion of these cases also allege blood clot related injuries including deep vein thrombosis and pulmonary embolism. Bayer recently said that it set aside $1.5 billion for litigation costs.
Yaz, Yasmin Blood Clot Risk
Yaz and Yasmin contain the synthetic hormone drospirenone; research has found that these types of oral contraceptives have a higher risk of leading to blood clots. Last April, the U.S. Food and Drug Administration (FDA) updated the label on Yaz, Yasmin and other birth control pills containing drospirenone to warn that the risk may be three times as high in women taking these types of birth control pills. A recent study funded by the agency also found that use of birth control pills containing drospirenone was associated with a 77 percent increase in venous thromboembolic events and a two-fold increased risk of arterial thromboembolic events.